0001493152-20-024462.txt : 20201229
0001493152-20-024462.hdr.sgml : 20201229
20201229164416
ACCESSION NUMBER: 0001493152-20-024462
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201207
FILED AS OF DATE: 20201229
DATE AS OF CHANGE: 20201229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BROIDRICK AMY S.
CENTRAL INDEX KEY: 0001822917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37428
FILM NUMBER: 201422957
MAIL ADDRESS:
STREET 1: 1440 VALLE GRANDE
CITY: ESCONDIDO
STATE: CA
ZIP: 92025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001460702
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263474527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 2042 CORTE DEL NOGAL
STREET 2: CARLSBAD
CITY: CALIFORNIA
STATE: CA
ZIP: 92011
BUSINESS PHONE: (760) 918-9165
MAIL ADDRESS:
STREET 1: 2042 CORTE DEL NOGAL
STREET 2: CARLSBAD
CITY: CALIFORNIA
STATE: CA
ZIP: 92011
FORMER COMPANY:
FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20090402
4
1
ownership.xml
X0306
4
2020-12-07
0
0001460702
Qualigen Therapeutics, Inc.
QLGN
0001822917
BROIDRICK AMY S.
C/O QUALIGEN THERAPEUTICS, INC.,
2042 CORTE DEL NOGAL
CARLSBAD
CA
92011
1
1
0
0
Executive VP, CSO
Stock Option (Right to Buy)
3.52
2020-12-07
4
A
0
150000
0
A
2030-12-07
Common Stock
150000
150000
D
Shares underlying the stock option vest over three years in equal annual installments from the date of grant.
/s/ Hayden Trubitt, Attorney-in-Fact for Amy S. Broidrick
2020-12-29